Investment Summary |
|
|---|---|
| Date | 2020-10-15 |
| Target | Veritas Intercontinental |
| Sector | Life Science |
| Investor(s) |
Charme Capital Partners
Amadeus Capital Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2002 |
| PE ASSETS | 1.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
Charme Capital Partners is a private equity firm focused on acquiring and investing mid-sized European companies valued from €100 to €500 million. The Firm has a particular interest in companies located in the UK, Spain, and Italy exhibiting strong growth prospects and operating in a range of business sectors. Charme Capital Partners was established in 2003 and has offices in London, Milan, and Madrid.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 18 |
| Sector: Life Science M&A | 2 of 3 |
| Type: Venture M&A Deals | 1 of 1 |
| Country: Spain M&A | 5 of 6 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-21 |
ATOP
Barberino Val d’Elsa, Italy ATOP S.p.A. engages in the design and production of innovative machines and automatic lines for the high-growth market of electric traction for sustainable mobility (E-Mobility). ATOP S.p.A. is also active in the traditional automotive, household appliances and power tools sectors. ATOP operates with consolidated proprietary know-how, combined with the continuous search for innovative technological solutions also developed in co-design with its customers, well diversified in more than 380 companies and represented by well-known and innovative industrial groups worldwide. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-17 |
Bianalisi
Lissone, Italy Bianalisi is a network of laboratories and outpatient clinics present throughout most of the national territory. The Bianalisi Group offers efficient, high-quality, and low-cost diagnostic services. Bianalisi was founded in 1968 and is based in Lissone, Italy. |
Buy | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Amadeus Capital Partners is an early late-stage investor in high growth European technology companies. Specific areas of interest include AI & machine learning, online consumer services, cybersecurity, digital health and medical technology, digital media, enterprise SaaS, fintech, and insurtech. Amadeus Capital Partners was formed in 1997 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 62 of 68 |
| Sector: Life Science M&A | 6 of 6 |
| Type: Venture M&A Deals | 53 of 59 |
| Country: Spain M&A | 4 of 4 |
| Year: 2020 M&A | 10 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-14 |
Ori Biotech
London, United Kingdom Ori Biotech is a cell and gene therapy manufacturing technology company with a proprietary platform that automates and standardizes production. It enables developers to effectively scale advanced therapies from research to patients. Ori Biotech was founded in 2015 and is based in London, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-19 |
Pimloc
London, United Kingdom Pimloc specializes in deep learning systems for security video and diverse image collections. Pimloc’s technology powers products that enable private businesses and public organizations to protect sensitive or personal visual data, maintain safe online environments and manage video security footage. Pimloc was founded in 2016 and is based in London, United Kingdom. |
Buy | - |
